[Hemoglobinopathy].
Ohba Y.
Nihon Rinsho. 1995 Mar;53 Su Pt 2:177-9.
Hemoglobinopathy in India.
Iyer S, Sakhare S, Sengupta C, Velumani A.
Clin Chim Acta. 2015 Apr 15;444:229-33. doi: 10.1016/j.cca.2015.02.033. Epub 2015 Feb 23.
Genome editing coming of age for hemoglobinopathy.
Jiang H.
Mol Ther. 2023 Mar 1;31(3):601-602. doi: 10.1016/j.ymthe.2023.02.007. Epub 2023 Feb 16.
Distribution of Hemoglobinopathy in Nepalese Population.
Shrestha RM, Pandit R, Yadav UK, Das R, Yadav BK, Upreti HC.
J Nepal Health Res Counc. 2020 Apr 20;18(1):52-58. doi: 10.33314/jnhrc.v18i1.2303.
Endocrinopathies complicating transfusion-dependent hemoglobinopathy.
Al-Agha AE, Bawahab NS, Nagadi SA, Alghamdi SA, Felemban DA, Milyani AA.
Saudi Med J. 2020 Feb;41(2):138-143. doi: 10.15537/smj.2020.2.24845.
Advances in hemoglobinopathy detection and identification.
Troxler H, Kleinert P, Schmugge M, Speer O.
Adv Clin Chem. 2012;57:1-28. doi: 10.1016/b978-0-12-394384-2.00001-2.
Hemoglobinopathy as a Rare Differential Disease for Low Oxygen Saturation by Pulse Oximetry: A Case Report and Literature Review.
Takeda K, Sugiura T, Isomatsu S, Ogawa H, Murai Y, Miyata S, Imai S, Okaya T, Naito A, Sekine A, Shigeta A, Suzuki T.
Intern Med. 2025 Apr 1;64(7):987-991. doi: 10.2169/internalmedicine.4011-24. Epub 2024 Aug 28.
Neonatal hemoglobinopathy screening: molecular genetic technologies.
Bhardwaj U, Zhang YH, McCabe ER.
Mol Genet Metab. 2003 Sep-Oct;80(1-2):129-37. doi: 10.1016/j.ymgme.2003.08.014.
Targeting ZNF410 as a potential beta-hemoglobinopathy therapy.
Tumburu L, Thein SL.
Nat Genet. 2021 May;53(5):589-590. doi: 10.1038/s41588-021-00817-y.
Hemoglobinopathy or Analytical Interference?
Delacour H, Fontan E, Ceppa F.
Clin Chem. 2015 Sep;61(9):1214-5. doi: 10.1373/clinchem.2015.241091.
